Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1575 of 2026 entries
View as:

A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease

Phase: N/A Priority: Normal
NCT ID: NCT02564107 Org: User:
Start: 11/30/04 End: 04/30/06 Due: 04/30/07

A Study of Bevacizumab Plus 5-Flurouracil (5-FU) Based Doublet Chemotherapy as Neoadjuvant Therapy for Participants With Previously Untreated Unresectable Liver-Only Metastases From Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01695772 Org: User:
Start: 10/16/12 End: 05/12/16 Due: 05/12/17

A Study of Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01383707 Org: User:
Start: 08/12/11 End: 05/18/16 Due: 05/18/17

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab (TCZ) Administered to Participants With Giant Cell Arteritis (GCA).

Phase: N/A Priority: Normal
NCT ID: NCT03923738 Org: User:
Start: 08/05/19 End: 11/12/20 Due: 11/12/21

A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00316771 Org: User:
Start: 11/30/05 End: 03/31/08 Due: 03/31/09

A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00559754 Org: User:
Start: 12/31/07 End: 09/30/10 Due: 09/30/11

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Phase: N/A Priority: Normal
NCT ID: NCT01011738 Org: User:
Start: 04/11/09 End: 11/18/14 Due: 11/18/15

A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT05151731 Org: User:
Start: 12/31/21 End: 04/21/25 Due: 04/21/26

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Phase: N/A Priority: Normal
NCT ID: NCT02568267 Org: User:
Start: 11/19/15 End: 12/31/25 Due: 12/31/26

Ability of Muscle Imaging and Motor Function Measure (MFM) to Detect Changes in Disease Progression in Ambulant Spinal Muscular Atrophy Patients Compared to Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT02044029 Org: User:
Start: 01/31/14 End: 07/31/15 Due: 07/31/16

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT01018173 Org: User:
Start: 01/31/10 End: 01/31/11 Due: 01/31/12

A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens

Phase: N/A Priority: Normal
NCT ID: NCT03092739 Org: User:
Start: 05/03/17 End: 06/06/18 Due: 06/06/19

OPTIMA: An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Participants With Chronic Kidney Disease Stages 3 and 4 Not on Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT01902628 Org: User:
Start: 07/15/13 End: 09/04/16 Due: 09/04/17

A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Phase: N/A Priority: Normal
NCT ID: NCT00303589 Org: User:
Start: 12/31/05 End: 10/31/07 Due: 10/31/08

A Study of RO5024048 in Japanese and Caucasian Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01152671 Org: User:
Start: 06/30/10 End: 08/31/10 Due: 08/31/11

A Study of Risdiplam (RO7034067) in Adult and Pediatric Participants With Spinal Muscular Atrophy

Phase: N/A Priority: Normal
NCT ID: NCT03032172 Org: User:
Start: 03/03/17 End: 02/07/25 Due: 02/07/26

Effect of RO6871765 and RO7011785 on Immune Response With the Stimulation of Peripheral Blood Mononuclear Cells (PBMCs) in Chinese Healthy Volunteers and Chronic Hepatitis B Patients

Phase: N/A Priority: Normal
NCT ID: NCT02498275 Org: User:
Start: 07/31/14 End: 08/31/14 Due: 08/31/15

A Study of the Effectiveness of Peginterferon Alfa-2a (Pegasys) and Ribavirin Treatment in Slovenian Hepatitis C (HCV) Patients

Phase: N/A Priority: Normal
NCT ID: NCT02556307 Org: User:
Start: 03/31/09 End: 07/31/14 Due: 07/31/15

An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1)

Phase: N/A Priority: Normal
NCT ID: NCT01863693 Org: User:
Start: 05/10/13 End: 06/15/18 Due: 06/15/19

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS)

Phase: N/A Priority: Normal
NCT ID: NCT04428281 Org: User:
Start: 08/19/20 End: 07/31/25 Due: 07/31/26

A Study of The Relationship Between Drop in Hemoglobin and Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a)

Phase: N/A Priority: Normal
NCT ID: NCT01585324 Org: User:
Start: 01/31/12 End: 01/31/14 Due: 01/31/15

An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06047080 Org: User:
Start: 09/18/23 End: 12/31/30 Due: 12/31/31

A Study of RO6927005 Either As Monotherapy (Part A) or in Combination With Gemcitabine and Nab-Paclitaxel (Part B) to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Activity in Patients With Mesothelin-positive Metastatic and/or Locally Advanced Malignant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02317419 Org: User:
Start: 12/31/14 End: 08/31/15 Due: 08/31/16

A Study to Assess the Safety and Tolerability of Single and Multiple Ascending Doses of Oral RO7020531 in Chinese Healthy Participants.

Phase: N/A Priority: Normal
NCT ID: NCT03530917 Org: User:
Start: 05/15/18 End: 05/15/19 Due: 05/15/20

A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00535782 Org: User:
Start: 10/31/07 End: 01/31/11 Due: 01/31/12